Multimodal treatment efficacy differs in dependence of core symptom profiles in adult Attention-Deficit/Hyperactivity Disorder: An analysis of the randomized controlled COMPAS trial.

[1]  C. Bau,et al.  Feasibility trial of the dialectical behavior therapy skills training group as add-on treatment for adults with attention-deficit/hyperactivity disorder. , 2020, Journal of clinical psychology.

[2]  E. Feczko,et al.  Toward a Revised Nosology for Attention-Deficit/Hyperactivity Disorder Heterogeneity. , 2020, Biological psychiatry. Cognitive neuroscience and neuroimaging.

[3]  D. Coghill,et al.  Physical exercise in attention deficit hyperactivity disorder – evidence and implications for the treatment of borderline personality disorder , 2020, Borderline Personality Disorder and Emotion Dysregulation.

[4]  P. Bendtsen,et al.  Comorbidity of Adult ADHD and Its Subtypes With Substance Use Disorder in a Large Population-Based Epidemiological Study , 2019, Journal of attention disorders.

[5]  A. Koyuncu,et al.  Clinical Effects of ADHD Subtypes in Patients With Social Anxiety Disorder , 2019, Journal of attention disorders.

[6]  C. Jacova,et al.  Neuropsychological Performance Patterns of Adult ADHD Subtypes , 2019, Journal of attention disorders.

[7]  M. Abdel-Hamid,et al.  Effectiveness of Psychotherapy in Adult ADHD: What Do Patients Think? Results of the COMPAS Study , 2019, Journal of attention disorders.

[8]  M. Abdel-Hamid,et al.  Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms , 2019, JAMA network open.

[9]  Mira-Lynn Chavanon,et al.  Emotional dysregulation subgroups in patients with adult Attention-Deficit/Hyperactivity Disorder (ADHD): a cluster analytic approach , 2019, Scientific reports.

[10]  G. Migliarese,et al.  ADHD in adults: clinical subtypes and associated characteristics. , 2019, Rivista di psichiatria.

[11]  J. Halperin,et al.  A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD) , 2019, Front. Hum. Neurosci..

[12]  S. Gau,et al.  Psychiatric comorbid patterns in adults with attention-deficit hyperactivity disorder: Treatment effect and subtypes , 2019, PloS one.

[13]  F. Shokraneh,et al.  Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis , 2018, The lancet. Psychiatry.

[14]  D. Bijlenga,et al.  Persistence and Adherence to Psychostimulants, and Psychological Well-Being Up to 3 Years After Specialized Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Naturalistic Follow-Up Study , 2017, Journal of clinical psychopharmacology.

[15]  A. Soliman,et al.  False Memory in Adults With ADHD: A Comparison Between Subtypes and Normal Controls , 2017, Journal of attention disorders.

[16]  Alan M. Zaslavsky,et al.  The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys , 2017, ADHD Attention Deficit and Hyperactivity Disorders.

[17]  R. Chan,et al.  ADHD subtypes and neuropsychological performance in an adult sample. , 2016, Research in developmental disabilities.

[18]  A. Althouse.  Adjust for Multiple Comparisons? It's Not That Simple. , 2016, The Annals of thoracic surgery.

[19]  M. Abdel-Hamid,et al.  Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. , 2015, JAMA psychiatry.

[20]  Jan K. Buitelaar,et al.  Cognitive heterogeneity in adult attention deficit/hyperactivity disorder: A systematic analysis of neuropsychological measurements , 2015, European Neuropsychopharmacology.

[21]  Mark Olfson,et al.  Continuity in Methylphenidate Treatment of Adults With Attention-Deficit/Hyperactivity Disorder , 2007, Journal of managed care pharmacy : JMCP.

[22]  Mark R Schultz,et al.  False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. , 2014, Journal of clinical epidemiology.

[23]  A. Sjölander,et al.  Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. , 2014, JAMA psychiatry.

[24]  M. Abdel-Hamid,et al.  A randomized controlled multicenter trial on the multimodal treatment of adult attention-deficit hyperactivity disorder: enrollment and characteristics of the study sample , 2014, ADHD Attention Deficit and Hyperactivity Disorders.

[25]  M. Abdel-Hamid,et al.  German Validation of the Conners Adult ADHD Rating Scale–Self-Report , 2013, Journal of attention disorders.

[26]  E. Willcutt.  The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review , 2012, Neurotherapeutics.

[27]  D. Coghill,et al.  Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options , 2012, European Child & Adolescent Psychiatry.

[28]  J. Uekermann,et al.  German validation of the Conners Adult ADHD Rating Scales (CAARS) II: Reliability, validity, diagnostic sensitivity and specificity , 2012, European Psychiatry.

[29]  P. Hodgkins,et al.  Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population , 2011, Current medical research and opinion.

[30]  T. Hirvikoski,et al.  Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial. , 2011, Behaviour research and therapy.

[31]  David Rigau,et al.  Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder , 2011, CNS drugs.

[32]  M. Gerlach,et al.  Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial , 2010, Attention deficit and hyperactivity disorders.

[33]  J. Hebebrand,et al.  German Validation of the Conners Adult ADHD Rating Scales–self-report (CAARS-S) I: Factor Structure and Normative Data , 2010, European Psychiatry.

[34]  A. Nierenberg,et al.  Review of Medication Adherence in Children and Adults with ADHD , 2010, Postgraduate medicine.

[35]  R. Kilian,et al.  Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder , 2009, Journal of psychopharmacology.

[36]  M. Rietschel,et al.  Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment , 2008, European Psychiatry.

[37]  M. McDonagh,et al.  Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis , 2008, Psychopharmacology.

[38]  K. Rasmussen,et al.  Treatment of adult ADHD: Is current knowledge useful to clinicians? , 2008, European Psychiatry.

[39]  J. Johnston,et al.  Functional and psychosocial impairment in adults with undiagnosed ADHD , 2006, Psychological Medicine.

[40]  Susan Sprich,et al.  Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. , 2005, Behaviour research and therapy.

[41]  J. Thome,et al.  [Tools for the diagnosis of attention-deficit/hyperactivity disorder in adults. Self-rating behaviour questionnaire and diagnostic checklist]. , 2004, Der Nervenarzt.

[42]  S. Faraone,et al.  Meta-Analysis of the Efficacy of Methylphenidate for Treating Adult Attention-Deficit/Hyperactivity Disorder , 2004, Journal of clinical psychopharmacology.

[43]  P. Wender,et al.  [Wender Utah rating scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults]. , 2002, Der Nervenarzt.

[44]  L. Tebartz van Elst,et al.  Psychotherapy of attention deficit hyperactivity disorder in adults , 2002, European Archives of Psychiatry and Clinical Neuroscience.

[45]  R. Barkley,et al.  YOUNG ADULTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: SUBTYPE DIFFERENCES IN COMORBIDITY, EDUCATIONAL, AND CLINICAL HISTORY , 2002, The Journal of nervous and mental disease.

[46]  S. Lange,et al.  Adjusting for multiple testing--when and how? , 2001, Journal of clinical epidemiology.

[47]  S G Thompson,et al.  Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated , 1994, BMJ.

[48]  W. Retz.  Efficacy of Amphetamines, Methylphenidate, and Modafinil in the Treatment of Mental Disorders , 2021 .

[49]  W. Retz,et al.  [ADHD: Burden of Disease According to Subtypes in Adult Patients]. , 2015, Psychiatrische Praxis.